PAR Share Price Target 2030

CAGR-based price projection for Par Drugs And Chemicals Limited (PAR) targeting 2030, derived from official NSE exchange closing prices.

Bear Case (32.0% CAGR)
Rs 500
2030 Target
Base Case (79.9% CAGR)
Rs 1,729
2030 Target
Bull Case (290.9% CAGR)
Rs 38,519
2030 Target

Current Market Snapshot

CMP: Rs 164.95
52W High: Rs 168.25
52W Low: Rs 83.27
1Y CAGR: 223.8%
3Y CAGR: 79.9%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 218 Rs 297 Rs 645
2028 Rs 287 Rs 534 Rs 2,521
2029 Rs 379 Rs 961 Rs 9,854
2030 Rs 500 Rs 1,729 Rs 38,519

Other PAR Price Targets

2025 2026 2027 2028 2035 2040 2050

Frequently Asked Questions

What is the PAR share price target for 2030?

Based on historical growth analysis, the PAR share price target for 2030 ranges from Rs 500 (conservative) to Rs 1,729 (base case) to Rs 38,519 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of PAR?

The current market price of PAR (Par Drugs And Chemicals Limited) is Rs 164.95. The 52-week high is Rs 168.25 and 52-week low is Rs 83.27.

Is PAR a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for PAR price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 32.0% CAGR), Base (79.9% CAGR), and Bull (optimistic at 290.9% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.